Shares of BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report) were down 2.3% during mid-day trading on Monday . The company traded as low as $0.39 and last traded at $0.40. Approximately 380,070 shares changed hands during mid-day trading, an increase of 20,345% from the average daily volume of 1,859 shares. The stock had previously closed at $0.41.
BriaCell Therapeutics Trading Down 2.6 %
The company has a market capitalization of $298,532.40, a P/E ratio of 0.00 and a beta of 1.09. The business’s fifty day moving average price is $0.64 and its 200 day moving average price is $0.71.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Recommended Stories
- Five stocks we like better than BriaCell Therapeutics
- Low PE Growth Stocks: Unlocking Investment Opportunities
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- The How And Why of Investing in Oil Stocks
- 3 Steel Stocks Soaring After Tariff Announcements
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
